Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose CoQ10 in ALS
NCT00243932Phase 2Completed
- Sponsor
- Columbia University
- Start
- Apr 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of coenzyme q10 in amyotrophic lateral sclerosis (ALS) (3 arms), sponsored by Columbia University. Primary endpoint: ALS Functional Rating Scale-revised at 9 months. Started Apr 2005; status: completed.
02
Drugs
coenzyme q10
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00243932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243932.